2C-T-19

2C-T-19
Clinical data
Other names4-Butylthio-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-butylthiophenethylamine; 2C-T-Bu
ATC code
  • None
Identifiers
  • 2-[4-(butylsulfanyl)-2,5-dimethoxyphenyl]ethan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H23NO2S
Molar mass269.40 g·mol−1
3D model (JSmol)
  • COc1cc(SCCCC)c(cc1CCN)OC
  • InChI=1S/C14H23NO2S/c1-4-5-8-18-14-10-12(16-2)11(6-7-15)9-13(14)17-3/h9-10H,4-8,15H2,1-3H3 Y
  • Key:LGUVDOBGXUFUAJ-UHFFFAOYSA-N Y
  (verify)

2C-T-19, also known as 4-butylthio-2,5-dimethoxyphenethylamine, is a psychedelic phenethylamine of the 2C family. It was first synthesized by Alexander Shulgin.

Use and effects

In his book PiHKAL, Shulgin describes synthesis of the final intermediate of 2C-T-19 but did not bioassay the compound.[1]

Society and culture

Canada

As of October 31, 2016, 2C-T-19 is a controlled substance (Schedule III) in Canada.[2]

United States

In the United States, 2C-T-19 is not specifically scheduled, but possession and sales of 2C-T-19 could be prosecuted under the Federal Analog Act because of its structural similarities to 2C-T-7.

See also

References

  1. ^ Shulgin AT, Shulgin A (1991). "2C-T-19". PiHKAL: A Chemical Love Story (1st ed.). Berkeley, CA: Transform Press. ISBN 978-0-9630096-0-9. OL 22859055M.
  2. ^ "Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)". Canada Gazette. Vol. 150, no. 9. 4 May 2016.